The habit of putting handcuffs on human embryonic stem cell research might soon become a thing of the past, two news items point out today. Federal lawmakers want to get rid of three patents related to human embryonic stem cells, which could ease restrictions on future commercialization. In another report, the Senate will vote next month to overturn a presidential veto on federally funded new embryonic stem cell research.
Stem Cells Push Back
Apr 03, 2007